Juvéderm®
Commitment to
a Better You!
Cosmetic Specialties
What is JUVÉDERM®?

JUVÉDERM® is a smooth, replenishing injectable gel filler that we use to refresh
your appearance.  We will smooth away unwanted lines and bring back the
natural contours of your face.  You will get smooth and natural-looking results that
last up to a year.†

The exclusive formulation of JUVÉDERM® uses hyaluronic acid (HA), a naturally-
occurring sugar found in your body. It combines with the water in your skin to  
smooth lines and wrinkles, enhance lips, and restore lost volume to the
cheeks and jaw-line. In fact, hyaluronic acid facial fillers can even naturally
stimulate collagen production in your skin.1

Everyone will notice, but no one will know!


Where Does It Work?

Everyone’s skin ages differently and JUVÉDERM® may be used to rejuvenate
multiple problem areas.* From smile lines to vertical lip lines, you can smooth away
unwanted wrinkles and restore natural contours.



It’s Long Lasting

JUVÉDERM® is the ONLY Hyaluronic Acid filler FDA approved* to last up to one year
with one treatment (did we just say a year?).† That’s right, up to a year.



† This includes all JUVÉDERM® injectable gel formulations. Most subjects acquired optimal correction
at initial treatment.
1 Frank Wang, Luis A. Garza, Sewon Kang, James Varani, Jeffrey S. Orringer, Gary J. Fisher,
and John J. Voorhees. In Vivo Stimulation of De Novo Collagen Production Caused by Cross-
linked Hyaluronic Acid Dermal Filler Injections in Photodamaged Human Skin. Arch
Dermatol, Feb 2007; 143: 155 – 163
* In the United States, JUVÉDERM® is indicated for correction of moderate to severe facial wrinkles
and folds (such as nasolabial folds).
JUVÉDERM® XC Professional Full Fair Balance:

JUVÉDERM® XC Important Information

Indication

JUVÉDERM® XC injectable gel is indicated for injection into the mid-to-deep dermis
for correction of moderate to severe facial wrinkles and folds (such as nasolabial
folds).

IMPORTANT SAFETY INFORMATION

CONTRAINDICATIONS

JUVÉDERM® XC injectable gel should not be used in patients who have severe
allergies, marked by a history of anaphylaxis or history or presence of multiple
severe allergies, and should not be used in patients with a history of allergies to
gram-positive bacterial proteins or lidocaine.

WARNINGS

JUVÉDERM® XC injectable gel must not be injected into blood vessels and should
not be used in vascular-rich areas. Use in these areas, such as glabella and nose,
has resulted in cases of vascular embolization, occlusion of the vessels, ischemia or
infarction, or blindness. Symptoms of vessel occlusion and embolization include pain
that is disproportionate to the procedure or remote to the injection site, immediate
blanching extending beyond the injected area, and color changes that reflect
ischemic tissue such as a dusky or reticular appearance

Product use at specific sites in which an active inflammatory process (skin eruptions
such as cysts, pimples, rashes, or hives) or infection is present should be deferred
until the underlying process has been controlled

PRECAUTIONS

The safety and effectiveness for the treatment of anatomic regions other than facial
wrinkles and folds (such as lips) have not been established

As with all transcutaneous procedures, dermal filler implantation carries a risk of
infection. Follow standard precautions associated with injectable materials

The safety for use during pregnancy and in breastfeeding females has not been
established

The safety for use in patients under 18 years has not been established

The safety in patients with known susceptibility to keloid formation, hypertrophic
scarring, and pigmentation disorders has not been studied

JUVÉDERM® XC injectable gel should be used with caution in patients on
immunosuppressive therapy

Patients who are using products that can prolong bleeding (such as aspirin,
nonsteroidal anti-inflammatory drugs, and warfarin) may experience increased
bruising or bleeding at treatment sites

Patients should be limited to 20 mL of JUVÉDERM® XC per 60 kg (130 lbs) body
mass per year. The safety of injecting greater amounts has not been established

ADVERSE EVENTS
The most commonly reported side effects are temporary injection-site redness,
swelling, pain/tenderness, firmness, lumps/bumps, bruising, discoloration, and
itching. Most side effects are mild or moderate in nature, lasting 7 days or less.

To report a problem with JUVÉDERM® XC, please call Allergan Product Surveillance at
1-800-624-4261.

For more information, please see the About Safety page at www.juvederm.com
or call the Allergan Medical Information line at 1-800-433-8871.

JUVÉDERM® XC injectable gel is available by prescription only.
Ask us today about JUVÉDERM® treatments....
___________________________________________________________________________________________________________________________
Medical Disclaimer
The information on this web-site or by any links to or from this site is strictly presented for educational purposes only.  
This information is not a recommendation for a specific treatment plan, product, or course of action or medical or healthcare
provider.  In addition, this information may become out of date over time.  It is important that you see a healthcare professional
for detailed information about medical conditions and treatments.  This information is not intended to be a substitute for the advice
of a healthcare professional or a recommendation for any particular treatment plan.
___________________________________________________________________________________________________________________________

Site Map     Disclaimer     Privacy Statement     Contact Us         Copyright 2007 Summit Surgical Institute, LLC.  All Rights Reserved.